Prior to ElevateBio, Andrew worked in several leadership roles to oversee the successful implementation of strategic business development, marketing, and manufacturing operations. Notably, as Global Vice President of Business Development, Biologics for Catalent Pharma Solutions, Inc., his teams were responsible for driving revenue expansion, enabling the transformation of Catalent to a global biologics services provider.  

Prior to Catalent, Andrew held various leadership positions at Selexis Inc, Lonza Corporation, and Dow Chemical Company, creating strategic value through global business and licensing opportunities and increasing business unit profitability.

Most recently, Andrew was an Executive in Residence for Anzu Partners, Co-founder and Chief Executive Officer of VREX Therapeutics, and Founder, Inventor and Managing Director of Arthropod Biosciences.